Senior Clinical Data Manager jobs in United States
info-icon
This job has closed.
company-logo

Hemab Therapeutics · 9 hours ago

Senior Clinical Data Manager

Hemab Therapeutics is a clinical-stage biotechnology company focused on developing first-in-class prophylactic therapeutics for underserved bleeding and thrombotic disorders. They are seeking a Senior Clinical Data Manager to oversee data management activities, ensuring the quality and integrity of clinical trial data in alignment with regulatory requirements.

BiotechnologyLife ScienceMedicalPharmaceutical
Hiring Manager
Michelle Fisher
linkedin

Responsibilities

Oversee data management activities to ensure the quality and integrity of clinical trial data in alignment with regulatory requirements
Developing and maintaining clinical data management plans
Implementing data validation processes
Managing electronic data capture (EDC) systems
Collaborating with cross-functional teams to ensure successful trial execution
Managing study timelines and deliverables
Resolving data discrepancies
Preparing datasets and documentation for regulatory submissions

Qualification

Data ManagementClinical Data ManagementData ValidationElectronic Data Capture (EDC)Experience in bleeding disordersAttention to detailOrganizational skillsEffective communicationCollaboration skills

Required

Proficiency in Data Management and Clinical Data Management
Strong experience in Data Validation and quality assurance activities
Expertise in handling Clinical Data and familiarity with Electronic Data Capture (EDC) systems
Attention to detail, strong organizational skills, and ability to manage multiple projects simultaneously
Effective communication skills and ability to collaborate in a remote team environment
Bachelor's degree in Life Sciences, Data Science, or a related field; advanced degree is a plus

Preferred

Experience in bleeding or thrombotic disorders is beneficial

Company

Hemab Therapeutics

twittertwittertwitter
company-logo
Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

Funding

Current Stage
Growth Stage
Total Funding
$347M
Key Investors
Sofinnova PartnersAccess BiotechnologyNovo Holdings
2025-10-27Series C· $157M
2023-02-21Series B· $135M
2021-07-22Series A· $55M

Leadership Team

leader-logo
Benny Sørensen
Chief Executive Officer
linkedin
leader-logo
Mads Behrndt
Chief Financial Officer
linkedin
Company data provided by crunchbase